Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.250
-0.010 (-0.79%)
Aug 10, 2026, 9:30 AM EDT - Market open
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $72.38 million as of August 10, 2026. Its market cap has decreased by -40.87% in one year.
Market Cap
72.38M
Enterprise Value
18.72M
1-Year Change
-40.87%
Ranking
Category
Stock Price
$1.25
ChartMarket Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $72.38M, a decrease of -53.03%. That is a compound annual growth rate of -8.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 72.38M | -44.88% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 76.14M |
| Elicio Therapeutics | 74.81M |
| Acrivon Therapeutics | 74.05M |
| Inovio Pharmaceuticals | 73.24M |
| LeonaBio | 72.33M |
| Champions Oncology | 72.11M |
| Cingulate | 71.92M |
| OS Therapies | 71.26M |